Efficacy, safety, and economics of innovative medicines: the role of multi-criteria decision analysis and managed entry agreements in practice and policy

HIGHLIGHTS

  • who: Tanja Fens from the Department of Health Sciences, University Medical Center Groningen (UMCG), University of Groningen, Groningen, Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia have published the research work: Efficacy, Safety, and Economics of Innovative Medicines: The Role of Multi-Criteria Decision Analysis and Managed Entry Agreements in Practice and Policy, in the Journal: (JOURNAL)
  • what: Safety is the main focus in the majority (71%) of the aforementioned registries. It should be emphasized that patient monitoring obtained via registries is open-ended and serves for continuous observations, unlike the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?